triiodothyronine has been researched along with Bradycardia in 5 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Bradycardia: Cardiac arrhythmias that are characterized by excessively slow HEART RATE, usually below 50 beats per minute in human adults. They can be classified broadly into SINOATRIAL NODE dysfunction and ATRIOVENTRICULAR BLOCK.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In 23 patients with symptomatic severe supraventricular and ventricular tachyarrhythmias the effectiveness and the side effects of a long-term therapy with the class III antiarrhythmic drug Amiodarone (Cordarone) in a dosage of 100-800 mg/die in monotherapy and combination therapy were investigated." | 7.67 | [Long-term therapy with amiodarone in tachyarrhythmias--report on various experiences with special reference to its side effects]. ( Assmann, I, 1985) |
| "In 23 patients with symptomatic severe supraventricular and ventricular tachyarrhythmias the effectiveness and the side effects of a long-term therapy with the class III antiarrhythmic drug Amiodarone (Cordarone) in a dosage of 100-800 mg/die in monotherapy and combination therapy were investigated." | 3.67 | [Long-term therapy with amiodarone in tachyarrhythmias--report on various experiences with special reference to its side effects]. ( Assmann, I, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vlaeminck-Guillem, V | 1 |
| Espiard, S | 1 |
| Flamant, F | 1 |
| Wémeau, JL | 1 |
| Nataloni, IF | 1 |
| Ceriani, E | 1 |
| Foieni, F | 1 |
| Montano, N | 1 |
| Cicardi, M | 1 |
| BRAY, GA | 1 |
| Assmann, I | 1 |
| Wildenthal, K | 1 |
1 review available for triiodothyronine and Bradycardia
| Article | Year |
|---|---|
TRα receptor mutations extend the spectrum of syndromes of reduced sensitivity to thyroid hormone.
Topics: Abnormalities, Multiple; Adolescent; Adult; Age of Onset; Bradycardia; Child; Codon, Nonsense; Dwarf | 2015 |
4 other studies available for triiodothyronine and Bradycardia
| Article | Year |
|---|---|
A simple endocrinological cause of a complex cardiovascular picture.
Topics: Aged; Asthenia; Bradycardia; Dyspnea; Humans; Hypothyroidism; Male; Thyroiditis, Autoimmune; Thyrotr | 2010 |
EFFECTS OF RESERPINE ON THYROIDECTOMIZED-ANDRENODEMEDULLATED RATS.
Topics: Adrenal Medulla; Basal Metabolism; Blood Glucose; Body Temperature; Bradycardia; Carbon Dioxide; Dia | 1964 |
[Long-term therapy with amiodarone in tachyarrhythmias--report on various experiences with special reference to its side effects].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Benzofurans; Bradycardia; Drug Therapy, Combination; Elec | 1985 |
Responses to cardioactive drugs of fetal mouse hearts maintained in organ culture.
Topics: Acetylcholine; Animals; Arrhythmias, Cardiac; Bradycardia; Culture Techniques; Digitalis Glycosides; | 1971 |